| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |